Neurocrine Biosciences | L'Utile Ante Imposte



Pre Tax Profit Cambiamento Data
AbbVie USD 1.66B 3.15B 2025-03
Acadia Pharmaceuticals USD 40.21M 12.43M 2025-06
Agios Pharmaceuticals USD -112020000 22.73M 2025-06
ALKERMES USD 104.84M 79.35M 2025-06
Alnylam Pharmaceuticals USD -35358000 6.24M 2025-06
Amgen USD 1.57B 405M 2025-06
Biogen USD 744M 432.8M 2025-06
BioMarin Pharmaceutical USD 297.87M 59.78M 2025-06
Cytokinetics USD -134370000 27.01M 2025-06
Dynavax Technologies USD 21.22M 119.09M 2025-06
Exelixis USD 230.42M 24.72M 2025-06
Gilead Sciences USD 2.43B 780M 2025-06
Halozyme Therapeutics USD 204.94M 61.11M 2025-06
Incyte USD 558.01M 323.82M 2025-06
Ionis Pharmaceuticals USD 124M 271M 2025-06
Neurocrine Biosciences USD 159.5M 144.8M 2025-06
Pfizer USD 3.04B 259M 2025-06
Prothena USD -59501000 335K 2024-12
Regeneron Pharmaceuticals USD 1.52B 613.7M 2025-06
Repligen USD 27.36M 19.41M 2025-06
Sarepta Therapeutics USD 153.64M 537.16M 2025-06
Teva Pharmaceutical Industries USD 203M 91M 2025-06
Ultragenyx Pharmaceutical USD -114004000 35.77M 2025-06
Vertex Pharmaceuticals USD 1.28B 552.6M 2025-06


Neurocrine Biosciences L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.